September
2005
NEW THIS MONTH
**NEW**
ISPOR 2nd Asia-Pacific
Conference – ABSTRACT DEADLINE 12 SEPTEMBER 2005
**NEW**
ISPOR Research Digest Now
Includes 10th Annual International Meeting Contributed Research
**NEW**
ISPOR Publication
Discounts–NEW BOOKS
**NEW**
Value In Health "On-Line Early"
Manuscripts, Volume 8, Issue 5 & 6
**NEW**
ISPOR
Eighth Annual European Congress – UPDATES (OVER 700 CONTRIBUTED
PRESENTATIONS!)
**NEW**
ISPOR
Short Courses–ISPOR Eighth Annual European Congress & 11th
Annual International Meeting – UPDATES
**NEW**
ISPOR
Special Interest Group (SIG) – UPDATES
**NEW**
ISPOR Asia
Consortium–UPDATES
**NEW**
16
New Positions At The ISPOR Website
**SPECIAL
ANNOUNCEMENT**
Course in Economic Evaluations in Healthcare at Bocconi University
ISPOR ONGOING ACTIVITIES
1.
Publications
2.
Meetings
and Congresses
3.
Educational
Activities
4.
Student
News
5.
ISPOR
Special Interest Groups
6.
Committee
and Task Force Activities
7.
Hot
Topics
8.
Important
Dates to Remember
9.
Asia
Consortium and Local Chapter News
10. Employment
in Pharmacoeconomics and Outcomes Research
11.
Membership
- PUBLICATIONS
Top
VALUE IN HEALTH
Value
in Health: Volume
8, Issue 4, July/August 2005 is online and available this month at:
http://www.ispor.org/valueinhealth_index.asp.
The following is the TABLE OF CONTENTS for Value in Health Volume 8, Issue 4,
July/August 2005:
POLICY AND APPLICATION
Establishing the Cost-Effectiveness of New Pharmaceuticals
under Conditions of Uncertainty-When Is There Sufficient Evidence?
Mark Sculpher, Karl Claxton
DECISION-MAKER COMMENTARY
An Aging Population-Burden or Blessing?
Alan Williams
Evidence-Based Practice to Evidence-Based Policy: Do We
Really Impact on Patient Care?
Peter K. Wong
EMPIRICAL
Understanding Patient Preferences for HIV Medications Using
Adaptive Conjoint Analysis: Feasibility Assessment
Kathleen M. Beusterien, Kristina Dziekan, Emuella Flood,
Gale Harding, Jamie C. Jordan
Cost-Effectiveness Analysis of Rituximab Combined with CHOP
for Treatment of Diffuse Large B-Cell Lymphoma
Jennie H. Best, John Hornberger, Stephen J. Proctor, Louis
F. Omnes, Fred Jost
RELATIONSHIP BETWEEN INITIAL QUETIAPINE DOSE AND
EFFECTIVENESS AS REFLECTED IN SUBSEQUENT MENTAL HEALTH SERVICE USE AMONG
PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER
Frank Gianfrancesco, Ruey-hua Wang, Jacqueline Pesa
ELICITING WOMEN'S PREFERENCES FOR A
TRAINING PROGRAM IN BREAST SELF-EXAMINATION: A CONJOINT RANKING EXPERIMENT
Mickael Bech, Jan Sorensen, Jorgen
Lauridsen
COST SAVINGS FROM INTRAVENOUS
IMMUNOGLOBULIN MANUFACTURED FROM CHROMOTOGRAPHY/CAPRYLATE (IGIV-C) IN PERSONS
WITH PRIMARY HUMORAL IMMUNODEFICIENCY DISORDER
Parthiv J. Mahadevia, John Strell,
Dan Kunaprayoon, Erwin Gelfand
PERSISTENCE AND ADHERENCE OF
MEDICATIONS FOR CHRONIC OVERACTIVE BLADDER/URINARY INCONTINENCE IN THE CALIFORNIA MEDICAID PROGRAM
Yanni F. Yu, Michael B. Nichol,
Andrew P. Yu, Jeonghoon Ahn
COST AND UTILIZATION IMPACTS OF ORAL ANTIHISTAMINES IN THE CALIFORNIA MEDI-CAL PROGRAM
Joel W. Hay, Michael Leahy
VALUE IN HEALTH "ON-LINE EARLY" MANUSCRIPTS
Volume 8,
Issue 5, September/October 2005 "On-Line Early" will go on-line later
this month. To view these "On-Line Early" articles, simply go to
http://www.ispor.org/valueinhealth_index.asp,
log on using your membership information, and follow the link.
ISPOR CONNECTIONS
ISPOR CONNECTIONS: Volume 11, Issue 4, July/August 2005 is now available
to the public at:
http://www.ispor.org/news/index_new.asp.
HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS
"The
ISPOR Book of Terms has been a real hit with our customers and employees
alike. It fills a gap for those who are new to Outcomes." Jenifer Ehreth, PhD, Director Reimbursement for Europe,
Middle East and Africa Medtronic Europe
This ISPOR
publication includes more than 100 detailed monographs covering over 400 terms
used in health care delivery, management, and regulation, as well as health
care outcomes research including clinical, economic, and quality-of-life
research terms. ISPOR member discounted price is $36.00; a 40%
discount! Student/Library/Academic discounted price: $33.00 (a 45%
discount). On-line ordering is now available at:
http://www.ispor.org/publications/lexicon_index.asp.
Contact Stephen Priori at
spriori@ispor.org for information on
orders over 100.
**NEW**PUBLICATION DISCOUNTS–FOR
ISPOR MEMBERS INCLUDES NEW BOOKS
ISPOR membership includes special discount prices on
clinical, drug, pharmacoeconomics, health economic, quality of life,
statistics, epidemiology, health-care purchasing, outcomes research and disease
management reference books and journals. A select group of publications are
offered to ISPOR members at discounted prices.
New books included with ISPOR member
discounts are:.
**USING COST-EFFECTIVENESS ANALYSIS TO IMPROVE
HEALTH CARE (Oxford University Press) By Peter J. Neumann
ISPOR Members Cost: $28.00 (a 20% savings).
**METHODS FOR THE ECONOMIC EVALUATION OF HEALTH
CARE PROGRAMS (Third Edition) (Oxford University Press)
By Michael Drummond
ISPOR Members Cost: $44.00 (a 20% savings).
**CHOICES,
VALUES, AND FRAMES (Cambridge University Press)
Edited By Daniel
Kahneman and Amos Tversy
ISPOR Members Cost:
$39.19
**WELL-BEING:
FOUNDATIONS OF HEDONIC PSYCHOLOGY (Russell Sage Foundation)
Edited by Daniel
Kahneman, Ed Dinear, and Norbert Schwartz
ISPOR Members Cost:
$28.00
**EVALUATING
PHARMACEUTICALS FOR HEALTH POLICY AND REIMBURSEMENT (Blackwell Publishing)
By Nick Freemantle
and Suzanne Hill
ISPOR Members Cost: $47.97 (a 40% savings)
To see all books & journals with ISPOR member disounts,
go to:
http://www.ispor.org/members/pubdiscount.asp
- ISPOR MEETINGS AND CONGRESSES
Top
ISPOR EIGHTH ANNUAL
EUROPEAN CONGRESS –OVER 850 ABSTRACTS SUBMITTED FOR THE ISPOR EIGHTH ANNUAL
EUROPEAN CONGRESS - UPDATES
6-8
November 2005 Palazzo Degli Affari, Florence , Italy
"INCORPORATING
VALUES INTO HEALTH CARE DECISIONS"
For more information on the ISPOR 8th
Annual European Congress visit:
http://www.ispor.org/congresses/italy1105/index.asp
Posters & Podiums - *New ISPOR Record
Over 700 contributed presentations
(64 podium presentations in 4 sessions and over 600 posters in 3
sessions)! This is the highest number of abstract submissions and
presentations in ISPOR's 10-year history.
Poster Session I:
http://www.ispor.org/congresses/italy1105/posters1.asp
Poster Session II:
http://www.ispor.org/congresses/italy1105/posters2.asp
Poster Session III:
http://www.ispor.org/congresses/italy1105/posters3.asp
For poster and podium presentation
information, visit:
http://www.ispor.org/congresses/italy1105/presenters_index.asp
ISPOR Contributed Issue Panels:
Nine contributed Issue Panels on the following
topics:
*Economic Outcomes Issues
*Clinical Outcomes Issues
*Quality of Life / Patient Reported Outcomes Issues
*Health Policy – Health Care Reimbursement Issues
*Risk Management Issues
ISPOR Contributed Workshops:
Thirty-two workshops on the following topics:
*Medication Compliance & Persistence
*Risk Management
*Population Health
*Managed Care Formulary Dossier Development or
Research Agendas
*Patient Registries
*Health Technology Assessment
SPECIAL EVENT:
You Are Invited To Attend The
ISPOR 10th Anniversary Party
Vincigliata Castle
Feisole, Italy
(TO BE HELD
DURING THE ISPOR 8TH EUROPEAN CONGRESS)
MONDAY, 7 NOVEMBER 2005
20:00-23:30
WINE TASTING 
DINNER
BUFFET
MUSIC & DANCING
COMPLIMENTARY TRANSPORTATION
Buses will depart the Palazzo Delgi Affari at 20:15
and depart the Castle at 23:30. To register, go to:
http://www.ispor.org/congresses/italy1105/10annivparty.asp
Exhibitor Opportunities available at:
https://www.ispor.org/Exhibit_Sponsor/ExhibitorOpportunities.aspx?event=3
Sponsorship Opportunities available at:
https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=3
For more details about the Congress, go to:
http://www.ispor.org/congresses/italy1105/index.asp
********************************************************************************
ISPOR 2nd ASIA-PACIFIC
CONFERENCE - UPDATES
Shanghai Worldfield Convention Hotel, Shanghai, China • 5-7 March 2006
IMPROVING EVIDENCE AND OUTCOMES IN HEALTH CARE
DECISION MAKING IN ASIA PACIFIC: CHALLENGE TO A NEW ERA
CO-ORGANIZED BY
ISPOR Asia Consortium
Fudan University, P.R. China
CO-SPONSORED BY:
Shanghai Municipal Government, P.R. China
Ministry of Labor and Social Security, P.R. China
Ministry of Health, P.R. China
State Food and Drug Administration, P.R. China
Shanghai City Food and
Drug Administration, P.R. China
Peking University,
P.R. China
The Chinese University of Hong Kong, P.R. China
Shanghai Academy of Social Sciences, P.R. China
Chinese Medical Association, P.R. China
Chinese Health Economics Association, P.R. China
Chinese Medical Doctor Association, P.R. China
China Licensed Pharmacist Association, P.R. China
Chinese Pharmaceutical Association, P.R. China
The Pharmaceutical Association of Thailand under the Royal Patronage, Thailand
China Social Insurance Association Medical Insurance Branch, P.R. China
Chinese Clinical Epidemiology Society, P.R. China
Chinese Cochrane Center,
P.R. China
For updates, please visit:
http://www.ispor.org/conferences/shanghai0306/sponsors.asp
ON-LINE ABSTRACT SUBMISSION DEADLINE: 12 SEPTEMBER
2005
Abstract submissions are invited for Contributed Research
and Contributed Workshop. Abstracts submitted to the 10th or 11th
Annual International Meeting or the 8th Annual European Congress can
be submitted to this Conference. All abstracts should be submitted through
http://ispor.confex.com/ispor/asia2/index.html.
SHORT COURSES:
Introduction to Pharmacoeconomics
Introduction to Quality of Life Assessment
Meta-Analysis and Systematic Literature Review
Introduction to Biostatistics in Clinical Trials
Introduction to Decision Analysis
Formulary Development
Budget Impact Analysis
Cost Analysis in Health Care
Retrospective Data Analysis
Modeling: Structure and Design of a Model
For further information, please visit:
http://www.ispor.org/conferences/shanghai0306/p030505.asp
1st Plenary Session:
Pharmacoeconomics and Outcomes Research Development and Use
in Asia
Moderator/Speaker:
Tony YH Tarn PhD, Director, Department of Pharmacy, Taipei City
Hospital, Taipei, Taiwan
Speakers:
Shanlian Hu, MD, MSc, Professor, School of Public Health, Fudan University,
Shanghai, China; Isao Kamae, MD, PH, Professor, Graduate School of
Medicine, Kobe University, Kobe, Japan, Syed Mohamed Aljunid, MD,
MSc, PhD, FAMM, Professor of Health Economics and Head of Department of
Community Health, and Faculty of Medicine, Universiti Kebangsaan Malaysia; Shu-Chen
Li, PhD, MS, MBA, Assistant Professor, Department of Pharmacy, National
University of Singapore, Singapore, Bong-Min Yang, PhD, Professor
of Economics and Dean, School of Public Health, Seoul National University,
South Korea; and Viroj Tangcharoensathien, PhD, Director of
International Health Policy Program Ministry of Public Health, Thailand.
2nd Plenary Session:
Development and Implementation of Pharmacoeconomics
Requirements: International Experiences
Moderator/Speaker: Wen Chen, PhD, Professor and Associate Dean, School of Public Health, Fudan University
Speaker: Suzanne Hill, PhD, Associate Professor, Clinical Pharmacology
Faculty of Health University of Newcastle, Australia
8 PODIUM SESSIONS, 8 WORKSHOP SESSIONS and 9
CO-SPONSORED SPECIALSESSIONS:
For details, go to:
http://www.ispor.org/conferences/shanghai0306/p030605.asp
http://www.ispor.org/conferences/shanghai0306/p030705.asp
FINANCIAL SUPPORT OPPORTUNITIES
Financial support opportunities are available at:
https://www.ispor.org/Exhibit_Sponsor/SponsorshipOpportunities.aspx?event=1
EXHIBITOR OPPORTUNITIES:
Exhibitor opportunities are available at:
https://www.ispor.org/Exhibit_Sponsor/ExhibitorOpportunities.aspx?event=1
EARLY REGISTRATIN DEADLINE: 5 FEBRUARY 2006
For further conference information, go to:
http://www.ispor.org/conferences/shanghai0306/index.asp
********************************************************************************
**NEW**
ISPOR Research Digest NOW
INCLUDES 10th Annual International Meeting Contributed
Research-UPDATE
The ISPOR RESEARCH DIGEST is an electronic database of over
5200 research papers presented at ISPOR Annual International Meetings,
ISPOR Annual European Congresses, and ISPOR Asia-Pacific Conferences from 1998
to May 2005. This database can be searched by disease, topic, and meeting. To
view the digest, go to:
http://www.ispor.org/research_study_digest/index.asp.
- EDUCATION ACTIVITIES
Top
ISPOR SHORT COURSES–ISPOR 8TH ANNUAL
EUROPEAN CONGRESS– UPDATES
Saturday,
6 November Short Courses:
Pharmacoeconomics for the
Health Care Decision-Maker
Faculty: Ralph Crott PhD, MPH, Health
Economist, Health Care Knowledge Center, Brussels, Belgium.
The Analysis and Interpretation
of Quality of Life and Patient Reported Outcomes
Faculty: Linda Abetz MA, Director, Questionnaire
Development and Validation, Mapi Values, Bollington, UK; Christine de la
Loge Director, Psychometrics and Statistics Mapi Values, Lyon, France.
European Databases and
Retrospective Database Analysis
Faculty: Bernd
Brϋggenjϋrgen MD, MPH, Coordinator-Health Economics, University of Berlin, Berlin, Germany.
Cost Estimation and
Assessing Financial (Budget) Impact of New Health Care Technologies
Faculty: Josephine Mauskopf PhD, Global Head, Health Economics and
Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, USA; C. Daniel Mullins PhD, Professor and
Chair of Pharmaceutical Health Services Research, University of Maryland,
School of Pharmacy, Baltimore, MD, USA.
Pharmacoeconomic Modeling
Faculty: Uwe Siebert MD, MPH, MSc, Decision Scientist, Director of
the Cardiovascular Research Program, Institute for Technology Assessment,
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA and
Director of the Program on Health Technology Assessment and Decision Sciences
(HTA&DS), Institute for Medical Informatics, Biostatistics, and
Epidemiology, University of Munich, Munich, Germany; Gaby Sroczynski MPH,
Decision Scientist, Institute for Technology Assessment, Massachusetts General
Hospital, Harvard Medical School, Boston, MA, USA and Bavarian Public Health
Research and Coordinating Center, University Munich, Germany.
For Saturday Short Courses
descriptions, go to:
http://www.ispor.org/congresses/italy1105/satsc.asp
Sunday,
6 November Short Courses:
Elements of
Pharmaceutical Pricing
Faculty: Jack
Mycka, President,
Optimar Strategic Consulting LLC, Montclair, NJ, USA; Renato Dellamano PhD,
President, ValueVector (Value Added Business Strategies), Milan, Italy
Transferability of
Cost-Effectiveness Data between Countries
Faculty: Michael Drummond PhD, Director, University of York, Centre for Health Economics, York, UK
Health Care and
Reimbursement Systems in Europe
Faculty: Gordon Carey Cambridge Pharma Consultancy Ltd., Cambridge, UK
Bayesian Methods in
Economic Evaluations
Faculty: Anthony O'Hagan PhD, Professor of Statistics,
University of Sheffield, Sheffield, South Yorkshire, UK; Jeremy E. Oakley
PhD, Lecturer, Department of Probability and Statistics, University of
Sheffield, Sheffield, UK; John Williams Stevens BSc, Statistician,
AstraZeneca, Leicestershire, UK
Discrete Event Simulation
for Economic Analysis
Faculty: J.
Jaime Caro MDCM, FCRPC, FACP, Adjunct Professor of Medicine, Adjunct Professor of
Epidemiology and Biostatistics, McGill University, Montreal PQ and Scientific
Director, Caro Research Institute, Concord, MA, USA; Jörgen Möller MSc Mech
Eng, Simulation Specialist, Caro Research Institute, Concord, MA, USA
Utility Measurements
(Preference-Based Techniques)
Faculty: Jan
Busschbach PhD,
Senior Investigator, Department for Medical Psychology and Psychotherapy and
Erasmus Medical Center, Rotterdam, The Netherlands; Elly Stolk MSc,
Institute for Medical Technology Assessment (iMTA), Erasmus University Medical
Center Rotterdam, The Netherlands.
For Sunday Short Courses
descriptions, go to:
http://www.ispor.org/congresses/italy1105/sunsc.asp
**************************
ISPOR SHORT COURSES–ISPOR 11TH ANNUAL INTERNATIONAL
MEETING – May 2006
Saturday,
May 20, 2006
Pharmacoeconomics for Decision-makers
Faculty: Lorne Basskin PharmD, Clinical Coordinator, Pharmacy Services, North Shore
Medical Center, Miami, FL, USA and President, Trinka Publications, Cooper City,
FL, USA
Retrospective Database Analysis – Econometric Methods
Faculty: William H. Crown PhD, i3 Magnifi, Auburndale, MA, USA
Modeling: Design and Structure of a Model
Faculty: Marc Botteman MA, Managing Partner, PharMerit North America, Bethesda, MD , USA
Finding and Extracting Cost Data
Faculty: Judith A. O'Brien RN, BSPA, Vice President, Director of Cost
Development Research, Caro Research Institute, Concord, MA, USA
Bayesian Analysis: Overview
Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The
MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA
Financial Impact / Cost
of Illness
Faculty: Josephine Mauskopf PhD,
Global Head, Health Economics and Outcomes Strategy, RTI Health Solutions,
Research Triangle Park, NC, USA; C. Daniel Mullins PhD, Professor and
Chair of Pharmaceutical Health Services Research, University of Maryland,
School of Pharmacy, Baltimore, MD, USA
Bayesian Analysis: Applications
Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The
MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA
Qualitative Methods for Quality of Life/Patient-reported Outcomes
Faculty: Judith Barr, Associate Professor and Director, Northeastern
University, Boston, MA, USA
Sunday, May 21, 2006
Cost-Effectiveness Analysis alongside Clinical Trials
Faculty: TBD
Use of Real World Data in Outcomes Research
Faculty: TBD
Bayesian Analysis: Advanced
Faculty: Bryan Luce MBA, PhD, Founder and Senior Research Leader, The
MEDTAP Institute at United BioSource Corporation, Bethesda, MD, USA
Discrete Event Simulation for Economic Analyses
Faculty: J.Jaime Caro MDCM, FCRPC, FACP, Adjunct Professor of Medicine,
Adjunct Professor of Epidemiology and Biostatistics, McGill University,
Montreal PQ and Scientific Director, Caro Research Institute, Concord, MA, USA;
Jörgen Möller MSc Mech Eng, Simulation Specialist, Caro Research
Institute, Concord, MA, USA
Advanced Quantitative Methods for Quality of Life / Patient-Reported
Outcomes
Faculty: John Ware PhD, CEO & Chief Science Officer, Quality Metric
Incorporated, Lincoln, RI, USA
Elements of Pharmaceutical/Biotech Pricing I - Introduction
Faculty:
Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ,
USA;
Renato Dellamano PhD, President, ValueVector (Value Added Business
Strategies), Milan, Italy
Statistical Considerations in Economic Evaluations
Faculty:
Henry Glick PhD, University of Pennsylvania, School of Medicine,
Philadelphia, PA, USA; Jalpa Doshi PhD, University of Pennsylvania,
School of Medicine, Philadelphia, PA, USA;
Daniel Polsky PhD, University of Pennsylvania, School of Medicine,
Philadelphia, PA, USA
Propensity Scores and Comorbidity Risk Adjustment
Faculty:
Fadia Shaya MPH, PhD, Assistant Professor/Associate Director, University of Maryland School of Pharmacy, Center on Drugs and Public Policy, Baltimore, MD, USA
Patient Registries: Overview & Application
Faculty:
Jeff Trotter MBA, President, Ovation Research Group, Highland Park, IL, USA
Utility Measures in Health Economics and Outcomes Research
Faculty:
F. Reed Johnson PhD, Senior Fellow, RTI Health Solutions, Research Triangle Park, NC, USA
Outcomes Research for Medical Devices & Diagnostics
Faculty: TBD
Case Studies in Pharmaceutical/Biotech Pricing II – Advanced
Faculty:
Jack Mycka, President, Optimar Strategic Consulting LLC, Montclair, NJ,
USA; Renato Dellamano PhD, President, ValueVector (Value Added Business
Strategies), Milan, Italy
Risk Assessment: Analysis and Management
Faculty:
TBD
ISPOR DISTANCE LEARNING PROGRAM MODULES
http://www.ispor.org/distancelearning/index.asp
The following module topics are currently available (over 40
modules):
·
Pharmacoeconomics
·
Pharmacoeconomic
Evaluations & Methods
·
Cost-Effectiveness
Analysis
·
Cost-Benefit
Analysis
·
Cost-Utility
Analysis
·
Patient-Reported
Outcomes (Utilities, Health-Related Quality Of Life, Treatment
Satisfaction, Treatment Adherence, Patient Preferences)
·
Study Design in
Pharmacoeconomics
·
Guidelines
and Reference Standards
·
Pharmacoeconomics
in Drug Development, Reimbursement and Marketing
- STUDENT NEWS
Top
START AN ISPOR STUDENT CHAPTER! Over 30 student chapters! For more
information:
http://www.ispor.org/student/chapters_index.asp
POST YOUR RESUME ONLINE for employers to view for IPRAP – Internship –
Professional Recruitment Center
http://www.ispor.org/iprap/index.asp
For more details on the
ISPOR Student Network, please visit:
http://www.ispor.org/student/student_index.asp
-
ISPOR SPECIAL INTEREST GROUPS (SIG)
Top
VALUE-BASED REIMBURSEMENT SIG
For more details on this SIG, please visit:
http://www.ispor.org/sigs/reimbursement.asp
HEALTH TECHNOLOGY ASSESSMENT SIG
For more details on this SIG, please visit:
http://www.ispor.org/sigs/hta.asp
TRANSLATING RESEARCH TO CLINICAL PRACTICE SIG
For more details on this SIG, please visit:
http://www.ispor.org/sigs/cp.asp
PATIENT REGISTRY SIG
Member participation was recently solicited for this newly revived
Special Interest Group. The following are the Patient Registry SIG Working
Group chairs:
·
Safety-Surveillance
Working Group- Chair:
Peter Malamis
·
Analytical
Applications Working Group- Chair: Mohan Bala
·
Global
Applications Working Group- Co-Chairs: Leanne Larson and Melva Covington
·
Technology
Working Group- Chair: Hugh Levaux
Working Group Chairs are currently selecting Leadership
Group members. Those who indicated their interest in participating in the
groups above will be contacted and notified by the end of the month.
QUALITY OF LIFE SIG
For more details on this SIG, please visit:
http://www.ispor.org/sigs/qol.asp
MEDICATION COMPLIANCE & PERSISTENCE SIG
Issues
& Methods Working Group
This working
group is finalizing a manuscript, Medication Compliance and Persistence:
Consensus on Terminology and Definitions for submission to Value in
Health. The following poster will be on display in Poster Session III at the8th
European Congress:
PHP46: DEFINING COMPLIANCE/ADHERENCE AND
PERSISTENCE: ISPOR SPECIAL INTEREST WORKING GROUP
Burrell A1,
Wong P2, Ollendorf D3, Fuldeore M4, Roy A5, Fairchild C6, Cramer J7
1Sanofi-Aventis,
Bridgewater, NJ, USA; 2 Good Samaritan Hospital, Dayton, OH, USA; 3
PharMetrics, Inc, Watertown, MA, USA; 4 Walgreens Health Services, Deerfield,
IL, USA; 5 West Virginia University, Morgantown, WV, USA; 6 Alcon Laboratories,
Fort Worth, TX, USA; 7 Yale University School of Medicine, West Haven, CT, USA
Economics
of Medication Compliance Working Group
This
working group is working on two manuscripts for submission to Value in Health
incorporating compliance & persistence in Health Economics; and utilizing
game theory, the human capital approach and bilateral bargaining. A workshop
will be presented at the 8th European Congress on Monday 7 November
2006, at 10.45-11.45: W10: Incorporating Measure of Compliance &
Persistence In Pharmacoeconomic Evaluations.
Analyses
Standards Working Group
The manuscript
A Checklist for
Medication Compliance Studies Using Retrospective Databases is being finalized, and the group is working on a
checklist for prospective studies. A work
